Myomectomy is a surgical procedure performed to remove uterine fibroids but keep the uterus intact. Uterine fibroids or leiomyomas are common non-cancerous tumors that grow in or on the womb of women during their reproductive years. Symptoms of uterine fibroids include heavy painful periods, pelvic pressure or pain, increased menstrual bleeding, frequent urination, difficulty emptying the bladder, pain during sex, etc. Myomectomy allows women experiencing symptoms to preserve their fertility and avoid hysterectomy. The surgical technique involves making an incision in the abdomen or vagina and removing the fibroid tumors while repairing any damage to the uterus. Advantages of myomectomy over hysterectomy include preservation of the uterus and fertility potential of the woman.

The Global Myomectomy Market is estimated to be valued at US$ 791.2 MN in 2024 and is expected to exhibit a CAGR of 9.2% over the forecast period 2024 to 2031.

Key Takeaways:

Key players operating in the Global Myomectomy market are Medtronic, Stryker Corporation, CONMED Corporation, CooperSurgical Inc., Ethicon, Inc., Hologic, Inc., Minerva Surgical, Inc., INSIGHTEC, Karl Storz GmbH, Intuitive Surgical, and B. Braun Melsungen AG. These companies are focusing on launching innovative myomectomy devices and equipment to strengthen their market position.

The key growth driver for the Global Myomectomy Market Size is the rising prevalence of uterine fibroids among women worldwide. According to studies, uterine fibroids affect up to 70% of women by the age of 50. Growing awareness about the advantages of myomectomy over hysterectomy is also fueling the demand in the market.

Technological advancements like the introduction of minimally invasive surgical techniques such as laparoscopic and hysteroscopic myomectomy are supporting the growth of the Global Myomectomy market. These modern techniques reduce surgical risks, postoperative pain, hospital stay, and recovery time for patients compared to open abdominal myomectomy.

Market Trends:

1) Increasing adoption of robotic myomectomy: Roboticmyomectomy uses the Da Vinci Surgical System and offers benefits like high-definition 3D view, wristed instruments, tremor filtration and scalability. Its uptake is growing in developed countries.

2) Rising popularity of MRI-guided focused ultrasound: MRI-guided focused ultrasound (MRgFUS) is a non-invasive technique being used to destroy fibroid tumors through thermal ablation. It eliminates surgical risks and enables faster recovery.

Market Opportunities:

1) Emerging economies in Asia Pacific and Latin America: These regions are untapped markets for myomectomy devices and equipment providers due to increasing medical tourism and local demand.

2) Training and education programs: Launching specialized training workshops and certification programs for surgeons on modern techniques like robotic myomectomy can help expand the available pool of trained professionals.

Impact of COVID-19 on Global Myomectomy Market Growth

The COVID-19 pandemic has significantly impacted the growth of the global myomectomy market. In the initial phase of the pandemic, several non-emergency surgeries were postponed to avoid the spread of infection in hospitals and divert healthcare resources towards COVID-19 patients. This led to a decline in the number of myomectomy procedures performed worldwide during 2020 and 2021. Furthermore, travel restrictions and lockdowns imposed by various governments made it difficult for patients as well as healthcare professionals to reach hospitals for conducting or attending surgeries. This too hampered the market growth during the peak pandemic period. However, with the rollout of vaccination programs globally, the number of surgeries has gradually started increasing from late 2021. Still, concerns over new variants of coronavirus continues to pose challenges. Going forward, the market is expected to witness steady recovery as the pandemic situation stabilizes further and economies reopen completely. The key players need to focus on creating awareness about safety measures implemented in healthcare facilities to boost patient confidence and increase service uptake.

Geographical Regions with Highest Value for Global Myomectomy Market

In terms of value, North America accounts for the largest share in the global myomectomy market owing to factors such as high awareness levels, well-established healthcare infrastructure, and high adoption of advanced medical technologies. The United States represents the major revenue contributor within the region. Europe is the second largest market favored by rising gynecological disorders, increasing healthcare expenditure, and growing medical tourism. Asia Pacific is anticipated to witness the fastest growth during the forecast period due to large patient pool, improving access to healthcare facilities, and rising medical tourism in countries like India and Thailand. China and Japan also hold significant shares in the Asia Pacific regional market.

Fastest Growing Region for Global Myomectomy Market

Asia Pacific region is projected to experience the highest CAGR in the global myomectomy market during the forecast period. Factors driving the growth include rapidly developing healthcare infrastructure, rising healthcare expenditure, increasing awareness about women's health issues, and surging medical tourism in the region. In addition, large untapped opportunities, improving reimbursement scenarios, and growing focus of international players on Asia Pacific countries will contribute to the market expansion. In particular, India and China are anticipated to be the fastest emerging markets in the region with their huge patient bases, growing medical capabilities, and governments' efforts to strengthen public health systems. The boom in medical tourism due to affordable treatment costs will further support the market growth in Asia Pacific myomectomy market.

Get more insights on Myomectomy Market